Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The voltage-gated sodium-channel type IX α subunit, known as Na v 1.7 and encoded by the gene SCN9A, is located in peripheral neurons and plays an important role in action potential production in these cells.Recent genetic studies have identified Na v 1.7 dysfunction in three different human pain disorders.Gain-of-function missense mutations in Na v 1.7 have been shown to cause primary erythermalgia and paroxysmal extreme pain disorder, while nonsense mutations in Na v 1.7 result in loss of Na v 1.7 function and a condition known as channelopathy-associated insensitivity to pain, a rare disorder in which affected individuals are unable to feel physical pain.This review highlights these recent developments and discusses the critical role of Na v 1.7 in pain sensation in humans.Nonstandard abbreviations used: CIP, channelopathy-associated insensitivity to pain; DRG, dorsal root ganglion; Nav1.7, sodium channel encoded by SCN9A; PE, primary erythermalgia; PEPD, paroxysmal extreme pain disorder; SCN9A, voltage-gated sodium-channel type IX α subunit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344
Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81373-2 · Cited by 2,339
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.4 · Cited by 2,254
Self-citationAn SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,600
COMT val 158 met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor
Zubieta, J.-K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Stohler, C. S., & Goldman, D. (2003) · Science · doi:10.1126/science.1078546 · Cited by 1,125
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia
Yang, Y., Wang, Y., Li, S., Xu, Z., Li, H., Ma, L., Fan, J., Bu, D., Liu, B., Fan, Z., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.012153 · Cited by 801
Fertleman, C. R., Baker, M. D., Parker, K. A., Moffatt, S., Elmslie, F. V., Abrahamsen, B., Ostman, J., Klugbauer, N., Wood, J. N., Gardiner, R. M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.006 · Cited by 756
Nassar, M. A., Stirling, L. C., Forlani, G., Baker, M. D., Matthews, E. A., Dickenson, A. H., & Wood, J. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404915101 · Cited by 681
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors.
Gold, M. S., Reichling, D. B., Shuster, M. J., & Levine, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1108 · Cited by 668
Cited by
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025
“7 voltage-gated sodium channel (Drenth & Waxman 2007), may be considered peripherally mediated dysfunctional pain, but here the molecular causes are known.”
BackgroundThe Role of Voltage-Gated Sodium Channels in Pain Signaling
Bennett, D. L., Clark, A. J., Huang, J., Waxman, S. G., & Dib-Hajj, S. D. (2019) · Physiological Reviews · doi:10.1152/physrev.00052.2017 · Cited by 730
Self-citationValidating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
The NaV1.7 sodium channel: from molecule to man
Dib-Hajj, S. D., Yang, Y., Black, J. A., & Waxman, S. G. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3404 · Cited by 613
Self-citationSodium Channels in Normal and Pathological Pain
Dib-Hajj, S. D., Cummins, T. R., Black, J. A., & Waxman, S. G. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153234 · Cited by 607
Self-citationGain of function Na V 1.7 mutations in idiopathic small fiber neuropathy
Faber, C. G., Hoeijmakers, J. G. J., Ahn, H., Cheng, X., Han, C., Choi, J., Estacion, M., Lauria, G., Vanhoutte, E. K., Gerrits, M. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22485 · Cited by 557
Self-citationDavis, K. D., Aghaeepour, N., Ahn, A. H., Angst, M. S., Borsook, D., Brenton, A., Burczynski, M. E., Crean, C., Edwards, R., Gaudilliere, B., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0362-2 · Cited by 496
A Gain-of-Function Mutation in TRPA1 Causes Familial Episodic Pain Syndrome
Kremeyer, B., Lopera, F., Cox, J. J., Momin, A., Rugiero, F., Marsh, S., Woods, C. G., Jones, N. G., Paterson, K. J., Fricker, F. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.030 · Cited by 443
Breaking barriers to novel analgesic drug development
Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 364
Painful and painless channelopathies
Bennett, D. L. H., & Woods, C. G. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70024-9 · Cited by 348
Pain perception is altered by a nucleotide polymorphism in SCN9A
Reimann, F., Cox, J. J., Belfer, I., Diatchenko, L., Zaykin, D. V., McHale, D. P., Drenth, J. P. H., Dai, F., Wheeler, J., Sanders, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913181107 · Cited by 316
Self-citationGetting pharmaceutical R&D back on target
Bunnage, M. E. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.581 · Cited by 258
McCormack, K., Santos, S., Chapman, M. L., Krafte, D. S., Marron, B. E., West, C. W., Krambis, M. J., Antonio, B. M., Zellmer, S. G., Printzenhoff, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220844110 · Cited by 244
Inherited Neuronal Ion Channelopathies: New Windows on Complex Neurological Diseases
Catterall, W. A., Dib-Hajj, S., Meisler, M. H., & Pietrobon, D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3901-08.2008 · Cited by 237
“7, cause the painful neuropathy IEM, characterized by episodes of burning pain, erythema, and mild swelling in the hands and feet, which are triggered by mild warmth or exercise (Dib-Hajj et al., 2007; Drenth and Waxman, 2007).”
BackgroundSingle-nucleus transcriptomic analysis of human dorsal root ganglion neurons
Nguyen, M. Q., von Buchholtz, L. J., Reker, A. N., Ryba, N. J., & Davidson, S. (2021) · eLife · doi:10.7554/elife.71752 · Cited by 231
“several of these genes have deficits that recapitulate key effects of knocking out that gene in 46 mice (8, 18-21).”
BackgroundSmall-fibre neuropathies—advances in diagnosis, pathophysiology and management
Hoeijmakers, J. G., Faber, C. G., Lauria, G., Merkies, I. S., & Waxman, S. G. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.97 · Cited by 228
Self-citationCao, L., McDonnell, A., Nitzsche, A., Alexandrou, A., Saintot, P.-P., Loucif, A. J. C., Brown, A. R., Young, G., Mis, M., Randall, A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7653 · Cited by 202
Self-citationAlexandrou, A. J., Brown, A. R., Chapman, M. L., Estacion, M., Turner, J., Mis, M. A., Wilbrey, A., Payne, E. C., Gutteridge, A., Cox, P. J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152405 · Cited by 191
“7) have been identified in patients with congenital insensitivity to pain (CIP; [3]), whereas gain-of-function mutations in SCN9A lead to chronic pain syndromes such as paroxysmal extreme pain disorder (PEPD, [4]) and inherited erythromelalgia (IEM) [5] [6] [7] [8].”
BackgroundSelf-citationStatus of peripheral sodium channel blockers for non-addictive pain treatment
Alsaloum, M., Higerd, G. P., Effraim, P. R., & Waxman, S. G. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-00415-2 · Cited by 177
Self-citationThe transition from acute to chronic post surgical pain
Shipton, E. A. (2011) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1103900506 · Cited by 108
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients
Marchi, M., Salvi, E., Andelic, M., Mehmeti, E., D'Amato, I., Cazzato, D., Chiappori, F., Lombardi, R., Cartelli, D., Devigili, G., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000002905 · Cited by 29
“…from CIP to IE, PEPD, and SFN. 18 Although SCN9A variants in families with the early-onset EM and PEPD reported to date have full penetrance, 20 those identified in SFN patients showed incomplete penetrance and their impact on diseases pathogenesis is challenging because many nucleotides…”
Self-citationDuran, P., Loya‐López, S., Ran, D., Tang, C., Calderon‐Rivera, A., Gomez, K., Stratton, H. J., Huang, S., Xu, Y., Wijeratne, E. M. K., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15974 · Cited by 19
Metadata
- Authors
- Drenth, J. P. H., & Waxman, S. G.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3603-3609
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2109296561
- Cited by
- 370
- References
- 50
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.